P

P. Andrew Futreal

Wellcome Sanger Institute

ORCID: 0000-0001-8663-2671

Publishes on Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Acute Myeloid Leukemia Research. 1.4k papers and 167.8k citations.

PubIndex Score98Top 2%How it's scored

🌟#1 Current Senior Leader in Cancer Mechanisms and Therapy 🌟#4 Current Senior Leader in Melanoma and MAPK Pathways 🌟#10 Current Senior Leader in PI3K/AKT/mTOR signaling in cancer

1.4kPublications

167.8kTotal Citations

#1in Cancer Mechanisms and Therapy

First publication: 1991First senior author: 1993

Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers Acute Myeloid Leukemia Research Lung Cancer Treatments and Mutations CAR-T cell therapy research

Top publicationsby citations

The cancer genome

Michael R. Stratton, P. Andrew Futreal, Peter J. Campbell|Nature|2009

Cited by 3.5k

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett, Daniel A. Haber, Elena J. Edelman et al.|Nature|2012

Cited by 2.6k

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Simon Forbes, P. Andrew Futreal, Nidhi Bindal et al.|Nucleic Acids Research|2010

Cited by 2.3k

AACR Project GENIE: Powering Precision Medicine through an International Consortium

Fabrice André, Gordon B. Mills, Priti Kumari et al.|Cancer Discovery|2017

Cited by 2k

A comprehensive catalogue of somatic mutations from a human cancer genome

Erin Pleasance, Michael R. Stratton, R. Keira Cheetham et al.|Nature|2009

Cited by 1.7k